Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1109763612 | 11097636 | 12 | F | 20031021 | 20160727 | 20150507 | 20160728 | EXP | JP-009507513-1504JPN002086 | MERCK | 57.00 | YR | M | Y | 70.00000 | KG | 20160728 | CN | US | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1109763612 | 11097636 | 1 | PS | CRIXIVAN | INDINAVIR SULFATE | 1 | Oral | 800 MG, TID | Y | 20685 | 800 | MG | CAPSULE | TID | |||||
| 1109763612 | 11097636 | 2 | SS | STOCRIN TABLETS 200MG | EFAVIRENZ | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | FILM-COATED TABLET | |||||||||
| 1109763612 | 11097636 | 3 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | 300 MG, BID | Y | 0 | 300 | MG | CAPSULE | BID | |||||
| 1109763612 | 11097636 | 4 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | UNK | Y | 0 | CAPSULE | ||||||||
| 1109763612 | 11097636 | 5 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | 150 MG, BID | Y | 0 | 150 | MG | TABLET | BID | |||||
| 1109763612 | 11097636 | 6 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 1109763612 | 11097636 | 7 | SS | EPZICOM | ABACAVIR SULFATELAMIVUDINE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1109763612 | 11097636 | 1 | Acquired immunodeficiency syndrome |
| 1109763612 | 11097636 | 2 | Acquired immunodeficiency syndrome |
| 1109763612 | 11097636 | 3 | Acquired immunodeficiency syndrome |
| 1109763612 | 11097636 | 5 | Acquired immunodeficiency syndrome |
| 1109763612 | 11097636 | 7 | Acquired immunodeficiency syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1109763612 | 11097636 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1109763612 | 11097636 | Acute kidney injury | |
| 1109763612 | 11097636 | Fluid intake reduced | |
| 1109763612 | 11097636 | Immune system disorder | |
| 1109763612 | 11097636 | Nephrolithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1109763612 | 11097636 | 1 | 200005 | 20031117 | 0 | |
| 1109763612 | 11097636 | 2 | 20031205 | 0 | ||
| 1109763612 | 11097636 | 3 | 200005 | 20031117 | 0 | |
| 1109763612 | 11097636 | 4 | 20031205 | 2012 | 0 | |
| 1109763612 | 11097636 | 5 | 200005 | 20031117 | 0 | |
| 1109763612 | 11097636 | 6 | 20031205 | 2012 | 0 | |
| 1109763612 | 11097636 | 7 | 2012 | 0 |